Literature DB >> 17877483

Imaging of multistep human hepatocarcinogenesis.

Osamu Matsui1, Tosifumi Gabata, Satoshi Kobayashi, Noboru Terayama, Junn-Ichiro Sanada, Wataru Kouda, Hiroko Kawashima.   

Abstract

In Japan, there are approximately 32 000 deaths ( approximately 30 deaths per 100 000) per year due to hepatocellular carcinoma (HCC), and it is the third most common cancer in men and fifth in women. Approximately 90% of them are associated with chronic liver diseases due to hepatitis C or B virus infection. Therefore, it has become possible to detect small early stage HCC by the periodic screening in these high-risk patients group. During the screening imaging diagnosis of HCC, various kinds of hepatocellular nodules are also frequentlydetected. To characterize them is very important for the early diagnosis and treatment of HCC. For this purpose, it is necessary to understand the concept of multistep hepatocarcinogenesis and the sequential changes of imaging findings.

Entities:  

Year:  2007        PMID: 17877483     DOI: 10.1111/j.1872-034X.2007.00185.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  3 in total

Review 1.  Current status of imaging biomarkers predicting the biological nature of hepatocellular carcinoma.

Authors:  Norihide Yoneda; Osamu Matsui; Satoshi Kobayashi; Azusa Kitao; Kazuto Kozaka; Dai Inoue; Kotaro Yoshida; Tetsuya Minami; Wataru Koda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2019-02-02       Impact factor: 2.374

Review 2.  Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma.

Authors:  Jeong Min Lee; Jeong-Hee Yoon; Ijin Joo; Hyun Sik Woo
Journal:  Liver Cancer       Date:  2012-06       Impact factor: 11.740

3.  No Need of Immediate Treatment for Hypovascular Tumors Associated with Hepatocellular Carcinoma.

Authors:  Yutaka Midorikawa; Tadatoshi Takayama; Satoshi Nara; Takuya Hashimoto; Kiyohiko Omichi; Kiyoko Ebisawa; Tokio Higaki; Shingo Tsuji; Hirohiko Sakamoto; Kazuaki Shimada; Masatoshi Makuuchi
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.